Sunshine Guojian Pharmaceutical

同壁财经 · Jun 9 at 03:40 AM

Sunshine Guojian Pharmaceutical received a Wind ESG A rating, with a total score of 7.91

Wallstreetcn · Apr 6 at 08:41 PM

Innovative drug concept stocks rapidly plummeted, with NEPTUNUS hitting the daily limit, RemeGen falling more than 10%, and many stocks including Cosunter, Rundu Pharma, Sunshine Guojian Pharmaceutical, SL PHARM, and HITECK dropping more than 6%

Wallstreetcn · Mar 16 at 09:28 PM

Pharmaceutical stocks fluctuated and surged, with Getein Biotech hitting the daily limit, RemeGen rising nearly 7%, reaching a historical high. Sunshine Guojian Pharmaceutical, EASTON BIOPHARMACEUTICALS, YKYY, Junshi Biosciences, BeBetter Med, and InventisBio also followed suit

Zhitong · Nov 3, 2025 at 04:29 AM

Sunshine Guojian Pharmaceutical: Pfizer has registered two global Phase III clinical trials for the PD-1/VEGF dual antibody PF-08634404 (SSGJ-707) on a certain website, and the final payment remains uncertain

Zhitong · Nov 2, 2025 at 07:48 PM

A-share innovative drug concept stocks are active again, Sunshine Guojian Pharmaceutical rose over 10% to a new high, Yatai Pharm had two consecutive limit-ups, WECOME rose over 10%, and Baicheng Pharmaceutical, ALK, and Fushine followed suit

Zhitong · Oct 30, 2025 at 10:32 PM

Midday Review: The Beijing Stock Exchange 50 Index surged over 3% in the first half of the day, with strong performance in AI application sectors such as film and media